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+
Treatment Failure and 
Adherence in Second-
Line Patients.  
Results from an interview and photo-based research study looking at 
barriers and facilitators to adherence for second-line patients. 
+
What is treatment failure?  
  What is Viral load?  
  When?  
  What is high viral load  
  Following 1 high viral load, patients attend adherence 
counselling and a follow-up viral load is taken after 3 months.   
  Treatment failure 
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What is treatment failure?  
  What is Viral load?  
  When?  
4 and 12 months following treatment initiation.  
  What is high viral load  
 >1000 copies/mL 
  Following 1 high viral load, patients attend adherence 
counselling and a follow-up viral load is taken after 3 months.   
  Treatment failure = 2 consecutive high viral loads, need to 
change medication  
+
Adherence and resistance 
  What is Adherence to ARV's? 
  What is Resistance to ARV"s? 
+
What is 2nd line ARV's 
  1st line  
Efavirenz or Nevirapine 
  2nd line 
Aluvia or Kaletra 
  3rd line 
+
Background: Ubuntu Clinic 
Patients on second-line: 
  At the end of 2011, 6296 patients were 
receiving ART & 463 (7.4%) were on 2nd line 
treatment 
  Currently 20 new patients per month are 
starting second-line ART 
Second-line treatment failure: 
  After 5 years on ART, an estimated 14% of 
patients experienced laboratory virological 
failure & 12% were switched to second-line 
treatment 
  Second-line failure rates as high as 33% and 
40% have been found in South Africa.   
+
Study Purpose & Significance 
  Purpose:  To better understand the barriers and facilitators of 
second line adherence and treatment failure.  
  Significance:   
  As more HIV+ persons begin to take ARVs, rates of failure are 
increasing.   
  Treatment failures have no public option beyond second line ART 
in SA.  
  Patients who remain successful on first line often experience 
fewer side effects. 
  Addressing sub-optimal adherence early increases efficacy of 
treatment and decreases morbidity of patients.  
+
Study Structure 
  Interviews – both staff and patients at Ubuntu clinic were 
interviewed regarding their experience with second line 
ARVs 
  Staff interviews – 11 nurses, counselors and clinicians were 
interviewed 
  Patient interviews – 10 patients who had at least one high 
viral load on second line ARVs were interviewed. 
  Photovoice – 11 patients were asked to take photos of issues, 
situations and people in their lives affecting or affected by 
their medication. 
+
Summary of Barriers by Respondent  
+
Key Messages: Interviews 
  Lack of comfort/communication between staff & patients 
  “If you … are this formal person, then I won’t be open with you 
because you are too formal for me.  But if you are a down to earth 
person and understanding people for who they are, then its easy for 
people to just be comfortable and share.”  
  Patients experience problems that are not addressed.  
  “It was getting so difficult to take second-line.  It was a big pill and I 
decided to stop.”  
  “I have this diarrhea in my stomach and it’s cramping … it started my 
viral to go up and up and up because I skip now”  
+
Key Messages: Interviews 
  Education/miss-understanding of medication: 
  Many patients initially default on first line due to miss-
understood medication parameters. 
  “Before they said to us, if you used to take your tablets at 8 
o’clock in the morning or night you can’t take it at 9 o’clock 
because it’s too late.  But [later] said it’s not late, you must take 
the tablets.  If you forget, maybe it’s two hours or one hour, 
you can take your tablets.”  
  Re counseling: “It’s not enough… for 
those who are starting, they really need 
that 45 minutes or more, which we don’t 
get.” 
+
Key Messages: Interviews 
  Significance of relationships between staff and patients: 
  When relationships between staff and patients were good, 
it seemed to facilitate adherence and addressing 
problems.  
  “They got a big heart, you know, when you’ve come to tell 
them what’s going on with you.  They advise and then you 
believe it, that advice.” 
  However, where bad could affect a patients outlook on 
treatment. 
  “Then maybe it happens that day when you go to the 
clinic and then the nurse also doesn’t have a good day 
and then that clash would make us feel like I’m not going 
back.” 
+
Key Messages: Interviews 
  Need for positive support/encouragement: 
  Re counseling: “Its about preparing you for what you 
mentally are going to get into… it has to prepare you for 
whatever situation you get into.” 
  Re support group: “Knowing that we are all attending for 
second line, its easier to share … then I crave to see them 




  The table below lists frequency by main theme of photos 
shared during the photovoice workshop.  
+
Key PhotovoiceMessages 
  Overall message from photos was 
positive 
  The most recurrent negative aspect was 
the difficulty of continuing on treatment 
  The most important single idea 
communicated was the importance of a 
support structure (friends/family)  
  Patients used the exercise as a platform 
to share struggles and successes, 
highlighting the importance of having a 




  “I realised that 
there are parts of 
my life that I just 
blocked off and 
never faced … but 
now I have that 
mind that is telling 
me that I can face 
them again.” 
  “My husband passed away in 2006.  He was sick and then he 
passed away… then in, I think it was November 2007, I went 
for my first chemo.  The other difficult thing … was when I 
was disclosing to her and her brother, because he was asking 
why is she always sick, so I had to site down and disclose and 
that was the toughest day of my life.”  
+
Patient Profile 
  She was diagnosed with HIV in 2006 when she came to 
the clinic with TB.  While on first-line she drank alcohol 
to help with the stress.  Its now only herself, her sister 
and her two children.  She is the breadwinner in the 
family but her sister gives emotional support.  Both 
children are in school.   
  “Before I didn’t have any hope for taking these for the 
rest of my life.  But now I have changed things, you 
know, have seen that I am still alive.  By taking 
treatment I have changed my thinking, I am well and 
thinking I can do things and I will live long.”  
+
Misconceptions about ARV's 
  Dosing times 





Recommendations – TAC’s Role 
“The last decade was about access, this one is going to be 
about adherence.” 
  Educate patients on what treatment failure isand why it’s 
important 
  On-going education and support for patient adherence 
  Clear up common misconceptions about taking treatment  
  Promote good communicationbetween patients &healthcare 
workers 
